BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

American Medical Systems, Inc. (AMMD)'s GreenLight HPS(R) Approved for Use in Japan


5/5/2011 7:20:58 AM

MINNETONKA, Minn., May 4, 2011 /PRNewswire/ -- American Medical Systems® (AMS) (NASDAQ: AMMD), a leading provider of world-class devices and therapies for male and female pelvic health, today announced it has received clearance from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market and distribute its GreenLight HPS® laser therapy system for the treatment of Benign Prostatic Hyperplasia (BPH), or enlarged prostate, in Japan.

As the worldwide market leader in laser BPH treatment, AMS' GreenLight provides treatment with fewer side effects than TURP, improving clinical outcomes and patient safety for individuals with mild to severe BPH symptoms. The system is designed to enable the treatment of a wide range of gland sizes, as well as for patients on anti-coagulation therapy.

"We are thrilled to offer this leading-edge technology to provide a safer and less-invasive BPH treatment for Japanese men," said Mike Ryan, AMS' vice president and general manager for Asia Pacific, Latin America and Canada. "The approval of GreenLight represents a significant opportunity in Japan, as BPH is one of the most common diseases among older Japanese men, with the number of treatment procedures growing by over 4 percent each year."

GreenLight's high performance system (HPS) delivers efficient procedure times and the ability to treat large glands. The system will be offered in Japan through an exclusive distribution agreement with MC Medical, Inc., a subsidiary of Mitsubishi Corporation and a leading supplier of minimally invasive medical devices and supplies in Japan.

"Over 500,000 patients worldwide have been treated with GreenLight and with nearly 4 million men suffering from moderate to severe BPH symptoms in Japan, this is a great opportunity for us to help a growing population," Ryan said. "Not only does this expansion strengthen AMS' global presence but it also allows us to leverage MC Medical's highly regarded reputation within the Japanese urological community and its sales organization to reach key academic and private medical centers throughout the country."

For more information about AMS' GreenLight line of laser therapy systems for the treatment of BPH, visit http://www.americanmedicalsystems.com.

About American Medical Systems:

American Medical Systems, headquartered in Minnetonka, Minnesota, is a diversified supplier of medical devices and procedures to treat incontinence, erectile dysfunction, benign prostatic hyperplasia (BPH), pelvic floor prolapse and other pelvic disorders in men and women. These disorders can significantly diminish one's quality of life and profoundly affect social relationships. In recent years, the number of people seeking treatment has increased markedly as a result of longer lives, higher-quality-of-life expectations and greater awareness of new treatment alternatives. American Medical Systems' products reduce or eliminate the incapacitating effects of these diseases, often through minimally invasive therapies. The Company's products were used to treat approximately 340,000 patients in 2010.

More information about the Company and its products can be found at its website www.AmericanMedicalSystems.com and in the Company's Annual Report on Form 10-K for 2010 and its other SEC filings.

SOURCE American Medical Systems



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES